Malaysian Genomics Resource (MGRC)

Currency in MYR
0.200
+0.005(+2.56%)
Closed·
MGRC Scorecard
Full Analysis
Net income is expected to grow this year
MGRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2000.200
52 wk Range
0.1450.400
Key Statistics
Bid/Ask
0.19 / 0.225
Prev. Close
0.195
Open
0.2
Day's Range
0.2-0.2
52 wk Range
0.145-0.4
Volume
168.5K
Average Volume (3m)
447.3K
1-Year Change
-50.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MGRC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Malaysian Genomics Resource Company Profile

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests which inspects DNA for markers associated with genetic variations that influence various biological processes. The company also offers genome sequencing services for humans, animals, plants, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. In addition, it provides genome analysis services, including bioinformatics, trait analysis, and trio sequencing; genetic screening services, such as Dtect and Origene genetic screening test; and CAR T-cell immunotherapy treatment for different types of cancer. Further, it is involved in dealing in capital markets and derivative instruments; acting as general merchants; business relating to life sciences/cell lab and by products; and distribution of healthcare products, beauty products, and precision medicine. Additionally, the company provides system developments and information technology comprising software and hardware, as well as other human health services and general medical services. The company has research and development collaborations with Universiti Sains Malaysia; De Cell Berhad; Twsitcode Technologies Sdn Bhd; Kumpulan Medic Iman Sdn Bhd; Innoquest Pathology Sdn Bhd; and Kumpulan Perubatan Penawar Sdn Bhd and Hospotal Penawar Sdn Bhd. Malaysian Genomics Resource Centre Berhad was incorporated in 2004 and is headquartered in Petaling Jaya, Malaysia.

Compare MGRC to Peers and Sector

Metrics to compare
MGRC
Peers
Sector
Relationship
P/E Ratio
−7.8x−3.5x−0.5x
PEG Ratio
−0.100.000.00
Price/Book
1.6x1.1x2.6x
Price / LTM Sales
5.4x1.8x3.2x
Upside (Analyst Target)
-92.1%43.8%
Fair Value Upside
Unlock27.4%8.1%Unlock

Earnings

Latest Release
May 27, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
1.35M / --
EPS Revisions
Last 90 days

MGRC Income Statement

FAQ

What Stock Exchange Does Malaysian Genomics Trade On?

Malaysian Genomics is listed and trades on the Kuala Lumpur Stock Exchange stock exchange.

What Is the Stock Symbol for Malaysian Genomics?

The stock symbol for Malaysian Genomics is "MGRC."

What Is the Malaysian Genomics Market Cap?

As of today, Malaysian Genomics market cap is 27.44M.

What Is Malaysian Genomics's Earnings Per Share (TTM)?

The Malaysian Genomics EPS (TTM) is -0.03.

When Is the Next Malaysian Genomics Earnings Date?

Malaysian Genomics will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is MGRC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Malaysian Genomics Stock Split?

Malaysian Genomics has split 0 times.

How Many Employees Does Malaysian Genomics Have?

Malaysian Genomics has 16 employees.

What is the current trading status of Malaysian Genomics (MGRC)?

As of 01 Aug 2025, Malaysian Genomics (MGRC) is trading at a price of 0.20, with a previous close of 0.20. The stock has fluctuated within a day range of 0.20 to 0.20, while its 52-week range spans from 0.15 to 0.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.